 |
Superoxide dismutase (recombinant human) |
|---|---|
| Trade Name | Oxsodrol |
| Orphan Indication | Prevention of reperfusion injury to donor organ tissue |
| USA Market Approval | USA |
| USA Designation Date | 1988-05-17 00:00:00 |
| Sponsor | Bio-Technology General Corp.;70 Wood Avenue, South;Iselin, New Jersey, 08830 |
